US Court Revives Lawsuit Against Pfizer, Others on Iraq Terrorism Funding Claims

US Court Revives Lawsuit Against Pfizer, Others on Iraq Terrorism Funding Claims
A 3D printed Pfizer logo is placed near medicines from the same manufacturer in this illustration taken on Sept. 29, 2021. Dado Ruvic/Reuters
|Updated:

A U.S. appeals court on Tuesday revived a lawsuit against AstraZeneca Plc, Pfizer Inc and other companies over allegations their contracts with Iraq’s health ministry helped fund terrorism that killed Americans during the war in Iraq.

The plaintiffs contend that the militia group Jaysh al-Mahdi, sponsored by the terrorist group Hezbollah, controlled Iraq’s health ministry and that the 21 defendant U.S. and European medical equipment and pharmaceutical companies made corrupt payments to obtain medical-supply contracts.